Aug. 3, 2005 — ARCH Venture Partners announced that Steven Gillis has joined the firm as a partner based out of its Seattle office.
He will focus on assisting in the development and growth of biotechnology portfolio companies and will assume board roles in a number of companies. He is also expected to be active in the evaluation of new life science technologies.
Gillis was director of research and development, chief scientific officer, and eventually chairman and CEO of Immunex Corp., which he co-founded in 1981, and which was acquired by Amgen in 2001. Gillis also co-founded Corixa Corp. in 1994 where he served as chairman and CEO. Corixa was acquired by GlaxoSmithKline in 2005.